Language: BG BG
← Back to results
Recruiting Not applicable NCT04662905

Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain

No applicable phase (e.g. observational)
Conditions: Chronic Pain

Sponsor: Saluda Medical Pty Ltd

trial.available_in: БГ
Overview
The purpose of this study is to test and evaluate novel treatment delivery of ECAP-controlled closed loop SCS through the incorporation of new software and/or hardware features for patients with the Evoke System.
Who can participate
Inclusion Criteria: * 1\. Subject has undergone trial implant or is planning to be implanted with the Evoke System within its approved indication. * 2\. Subject is willing and capable of giving informed consent and able to comply with study-related requirements. Exclusion Criteria: N/A
Locations 1
Australia (1)
ACT Pain Centre
Garran , Australian Capital Territory
Technical details
Status
Recruiting
Phase
Not applicable
Study type
INTERVENTIONAL
Sex
Male and female
Minimum age
18 Years
Healthy volunteers
No
Start date
15.12.2020
Completion date
01.01.2027
Registry ID
NCT04662905
Source
anzctr
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.